Targeted anti-angiogenesis therapy for advanced osteosarcoma.

Area of Science:

• Oncology
• Biomedical Engineering
• Cancer Research

Background:

• Advanced osteosarcoma has a poor prognosis despite extensive research and current treatments like surgery, chemotherapy, and radiotherapy.
• Angiogenesis, the formation of new blood vessels, is closely linked to osteosarcoma tumorigenesis and development.
• Current anti-angiogenesis therapy shows insufficient efficacy in clinical trials, highlighting the need for improved strategies.

Purpose of the Study:

• To review the pathophysiological mechanisms of angiogenesis in osteosarcoma.
• To summarize recent advances in anti-angiogenesis treatment for osteosarcoma.
• To provide insights for improving osteosarcoma treatment strategies and patient prognosis.

Main Methods:

• Literature review of pathophysiological mechanisms of angiogenesis in osteosarcoma.
• Analysis of recent advances in anti-angiogenesis therapies.
• Discussion of relevant clinical studies and treatment outcomes.

Main Results:

• Angiogenesis plays a critical role in osteosarcoma progression.
• Existing anti-angiogenesis therapies have limitations in clinical efficacy.
• Further investigation into treatment failure causes is required.

Conclusions:

• Reevaluation of current osteosarcoma treatment strategies is essential.
• Understanding angiogenesis mechanisms can guide the development of novel therapies.
• Improving anti-angiogenesis approaches holds promise for better patient prognosis.